Recherche
-
Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
(British Journal of Haematology, 2023-04-20)Article de revueLibre accès -
Exacerbation of thrombo-inflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis.
(Blood Advances, 2024-02-22)Article de revueLibre accès -
Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms
(The Journal of Maternal-Fetal & Neonatal Medicine. vol. 33, n° 1, pp. 49–56, 2020)Article de revueAccès réservé -
Anti-Glucosylsphingosine Autoimmunity, JAK2V617F-Dependent Interleukin-1β and JAK2V617F-Independent Cytokines in Myeloproliferative Neoplasms.
(Cancers. vol. 12, n° 9, 2020-08-28)Article de revueLibre accès -
Effect of flumazenil on diaphragm electrical activation during weaning from mechanical ventilation after acute respiratory distress syndrome
(British Journal of Anaesthesia. vol. 114, n° 2, pp. 269–275, 2015-02)Article de revueAccès réservé -
A novel rare c.-39C>T mutation in the PROS1 5'UTR causing PS deficiency by creating a new upstream translation initiation codone
(Clinical Science. vol. 134, n° 10, pp. 1181-1190, 2020)Article de revueLibre accès -
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
(British Journal of Haematology. vol. 190, n° 4, pp. e224-e229, 2020-01-01)Article de revueLibre accès -
Response to commentary "The importance of assessing left ventricular longitudinal function in presence of increased afterload".
(Critical Care. vol. 28, n° 1, pp. 103, 2024-03-29)Article de revueLibre accès -
Antigenic Mimicry in Paraneoplastic Immune Thrombocytopenia
(Frontiers in Immunology. vol. 10, pp. 523, 2019-03)Article de revueLibre accès -
Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.
(Experimental Hematology & Oncology. vol. 12, n° 1, pp. 50, 2023-05-30)Article de revueLibre accès